Synapse - Find an Expert

1159 Results

Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors

Journal Article

Garcia-Rendueles, M. E. R.; Krishnamoorthy, G.; Saqcena, M.; Acuña-Ruiz, A.; Revilla, G.; de Stanchina, E.; Knauf, J. A.; Lester, R.; Xu, B.; Ghossein, R. A.; more...
Molecular Cancer (2022)

Fulltext@MSK | Save

Levoketoconazole treatment in endogenous Cushing’s syndrome: Extended evaluation of clinical, biochemical, and radiologic outcomes

Journal Article

Fleseriu, M.; Auchus, R. J.; Greenman, Y.; Zacharieva, S.; Geer, E. B.; Salvatori, R.; Pivonello, R.; Feldt-Rasmussen, U.; Kennedy, L.; Buchfelder, M.; more...
European Journal of Endocrinology (2022)

Fulltext@MSK | Save

Calcium channel blockers used concomitantly with insulin Secretagogues and serious hypoglycemia

Meeting Abstract

Nam, Y. H.; Brensinger, C. M.; Bilker, W. B.; Flory, J.; Leonard, C. E.; Hennessy, S.
Pharmacoepidemiology and Drug Safety (2022)

Fulltext@MSK | Save

Validation of an international classification of disease (ICD) 10 algorithm for hypoglycemia in administrative claims data

Meeting Abstract

Her, Q.; Dejene, S.; Min, J. Y.; Pate, V.; Funk, M. J.; Flory, J.
Pharmacoepidemiology and Drug Safety (2022)

Fulltext@MSK | Save

Preoperative glucose associations with adverse outcomes are rendered insignificant after controlling for frailty in geriatric surgical oncology patients

Meeting Abstract

Huang, A. L.; Flory, J.
Journal of the American College of Surgeons (2022)

Fulltext@MSK | Save

Targeting insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in metastatic, PIK3CA-mutant, hormone receptor-positive breast cancer

Meeting Abstract

Shen, S.; Salehi, E.; Farooki, A.; Flory, J.; Williams, D.; Carpio, A.; Chang, C.; Lacouture, M. E.; Andreopoulou, E.; Sardesai, S. D.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Long-term outcomes of adrenal insufficiency (AI) due to anti-PD(L)-1 immune checkpoint inhibitors (ICI) among patients with cancer

Meeting Abstract

Nguyen, B.; Shah, N. J.; Knezevic, A.; Newman, S.; Fitzgerald, K. N.; Kotecha, R.; Lee, C. H.; Carlo, M. I.; Aggen, D. H.; Feldman, D. R.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

EPIK-B4: A phase 2, randomized study of metformin (MET) extended release (XR) +/- dapagliflozin (DAPA) to prevent hyperglycemia (HG) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated (mut) advanced breast cancer (ABC) treated with alpelisib (ALP) and fulvestrant (FUL)